The Valley Desk

NCT00081315 · Interventional trial

Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer

Overall registry status Completed

Phase 2

Conditions Esophagitis, Non-Small Cell Lung Carcinoma, Pneumonitis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov